Egbert Flory

3.7k total citations · 1 hit paper
59 papers, 3.0k citations indexed

About

Egbert Flory is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Egbert Flory has authored 59 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Immunology and 17 papers in Virology. Recurrent topics in Egbert Flory's work include HIV Research and Treatment (15 papers), Biomedical Ethics and Regulation (9 papers) and Virus-based gene therapy research (8 papers). Egbert Flory is often cited by papers focused on HIV Research and Treatment (15 papers), Biomedical Ethics and Regulation (9 papers) and Virus-based gene therapy research (8 papers). Egbert Flory collaborates with scholars based in Germany, United States and Netherlands. Egbert Flory's co-authors include Ulf R. Rapp, Klaus Cichutek, Carsten Münk, Angelika Hoffmeyer, Stephan Ludwig, Renate König, Heide Muckenfuß, Manfred Kunz, Johannes Löwer and Ulrike Held and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Egbert Flory

57 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SAMHD1 restricts HIV-1 infection in resting CD4+ T cells

2012 460 citations Xiaoyu Pan, Elina Erikson et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Egbert Flory Germany	27	1.2k	1.0k	963	662	436	59	3.0k
Michael T. Waring United States	18	820 0.7×	1.6k 1.5×	652 0.7×	421 0.6×	263 0.6×	26	2.8k
Yacov Ron United States	33	1.0k 0.8×	2.0k 1.9×	760 0.8×	392 0.6×	717 1.6×	79	3.8k
Dong Sung An United States	35	2.8k 2.3×	1.3k 1.2×	1.1k 1.2×	585 0.9×	601 1.4×	78	4.8k
Shinya Suzu Japan	30	909 0.7×	1.3k 1.3×	371 0.4×	292 0.4×	248 0.6×	96	2.7k
Jean‐Luc Battini France	26	1.2k 1.0×	1.1k 1.0×	661 0.7×	357 0.5×	222 0.5×	47	3.1k
Agustı́n Valenzuela-Fernández Spain	26	1.2k 0.9×	704 0.7×	583 0.6×	413 0.6×	467 1.1×	51	2.7k
Antonina Dolei Italy	33	957 0.8×	974 0.9×	378 0.4×	454 0.7×	253 0.6×	84	2.7k
K W Sell United States	25	909 0.7×	1.4k 1.3×	534 0.6×	410 0.6×	299 0.7×	63	3.4k
Yasuhiko Masuho Japan	34	1.8k 1.4×	1.5k 1.4×	263 0.3×	626 0.9×	172 0.4×	115	4.2k
Ashlee V. Moses United States	31	923 0.7×	1.5k 1.4×	1.2k 1.2×	1.3k 2.0×	694 1.6×	57	4.3k

Countries citing papers authored by Egbert Flory

Since Specialization

Citations

This map shows the geographic impact of Egbert Flory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Flory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Flory more than expected).

Fields of papers citing papers by Egbert Flory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egbert Flory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Flory. The network helps show where Egbert Flory may publish in the future.

Co-authorship network of co-authors of Egbert Flory

This figure shows the co-authorship network connecting the top 25 collaborators of Egbert Flory. A scholar is included among the top collaborators of Egbert Flory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egbert Flory. Egbert Flory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jung‐Klawitter, Sabine, et al.. (2023). Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1. Journal of Inherited Metabolic Disease. 47(3). 517–532. 1 indexed citations

Maier, Thorsten J., et al.. (2021). Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without. iScience. 24(3). 102170–102170. 29 indexed citations

Rieß, Maximilian, Nina V. Fuchs, Adam Idica, et al.. (2016). Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a. Journal of Biological Chemistry. 292(1). 264–277. 42 indexed citations

Celis, Patrick, Nicolas Ferry, Marit E. Hystad, et al.. (2015). Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014. Transfusion Medicine and Hemotherapy. 42(3). 194–199. 5 indexed citations

Salmikangas, Paula, Martina Schuessler‐Lenz, Patrick Celis, et al.. (2015). Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective. Advances in experimental medicine and biology. 871. 103–130. 48 indexed citations

Scherer, Jürgen & Egbert Flory. (2015). Klassifizierung von zellbasierten Arzneimitteln und rechtliche Implikationen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58(11-12). 1201–1206. 2 indexed citations

Barkholt, Lisbeth, Egbert Flory, Veronika Jekerle, et al.. (2013). Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints. Cytotherapy. 15(7). 753–759. 317 indexed citations

Flory, Egbert & Jens Reinhardt. (2013). European Regulatory Tools for Advanced Therapy Medicinal Products. Transfusion Medicine and Hemotherapy. 40(6). 409–412. 24 indexed citations

Pan, Xiaoyu, Elina Erikson, Sarah Schmidt, et al.. (2012). SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nature Medicine. 18(11). 1682–1688. 460 indexed citations breakdown →

10.

Berger, André, Andreas Sommer, Matthias Hamdorf, et al.. (2011). SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection. PLoS Pathogens. 7(12). e1002425–e1002425. 209 indexed citations

11.

Berger, André, Silke Schüle, & Egbert Flory. (2011). Die Zertifizierung neuartiger Therapien. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 54(7). 816–821. 2 indexed citations

12.

Perković, Mario, Stephen Norley, Ralf Sanzenbacher, et al.. (2010). SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic. Virology. 399(1). 87–97. 2 indexed citations

13.

Scheller, Carsten, Sieghart Sopper, Peifeng Chen, et al.. (2002). Caspase Inhibition Activates HIV in Latently Infected Cells. Journal of Biological Chemistry. 277(18). 15459–15464. 17 indexed citations

14.

Stitz, Jörn, et al.. (2002). Coreceptor Switch of [MLV(SIVagm)] Pseudotype Vectors by V3-Loop Exchange. Virology. 300(2). 205–216. 17 indexed citations

15.

Hoffmeyer, Angelika, Anne Große-Wilde, Egbert Flory, et al.. (1999). Different Mitogen-activated Protein Kinase Signaling Pathways Cooperate to Regulate Tumor Necrosis Factor α Gene Expression in T Lymphocytes. Journal of Biological Chemistry. 274(7). 4319–4327. 91 indexed citations

16.

Hoffmeyer, Angelika, Andris Avots, Egbert Flory, et al.. (1998). The GABP-responsive Element of the Interleukin-2 Enhancer Is Regulated by JNK/SAPK-activating Pathways in T Lymphocytes. Journal of Biological Chemistry. 273(17). 10112–10119. 54 indexed citations

17.

Wege, Helmut, et al.. (1994). Coronavirus Induced Encephalomyelitis: An Immunodominant CD4+ - T Cell Site on the Nucleocapsid Protein Contributes to Protection. Advances in experimental medicine and biology. 342. 413–418. 3 indexed citations

18.

Flory, Egbert, et al.. (1994). Recombinant Vaccinia Viruses Which Express MHV-JHM Proteins: Protective Immune Response and the Influence of Vaccination on Coronavirus-Induced Encephalomyelitis. Advances in experimental medicine and biology. 342. 401–406. 1 indexed citations

19.

Wege, H., et al.. (1993). An immunodominant CD4+ T cell site on the nucleocapsid protein of murine coronavirus contributes to protection against encephalomyelitis. Journal of General Virology. 74(7). 1287–1294. 19 indexed citations

20.

Flory, Egbert, et al.. (1993). Induction of protective immunity against coronavirus‐induced encephalomyelitis: Evidence for an important role of CD8⁺ T cells in vivo. European Journal of Immunology. 23(8). 1757–1761. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact